Anew Health Limited (AVG)

Anew Health Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2023
Cash & Equivalents	11.09	8.61	5.3
Short-Term Investments	1.04	1.02	10.7
Cash & Cash Equivalents	12.13	9.64	16
Cash Growth	-	-39.77%	-
Receivables	3.1	3.08	3.31
Other Current Assets	0.61	0.73	0.76
Total Current Assets	15.84	13.44	20.08
Property, Plant & Equipment	-	2.02	2.63
Goodwill and Intangibles	-	5.12	4.39
Other Long-Term Assets	-	3.98	2.87
Total Long-Term Assets	-	11.12	9.89
Total Assets	-	24.57	29.97
Accounts Payable	-	1	0.96
Deferred Revenue	-	16.5	23.99
Current Debt	-	2.5	2.13
Other Current Liabilities	20.56	1.21	0.73
Total Current Liabilities	20.56	21.21	27.81
Long-Term Debt	-	2.8	2.59
Total Long-Term Liabilities	-	2.8	2.59
Total Liabilities	-	24.01	30.4
Total Debt	4.16	5.3	4.71
Debt Growth	-	12.40%	-
Retained Earnings	-	0.51	-0.48
Comprehensive Income	-	0.05	0.05
Shareholders' Equity	3.5	0.56	-0.43
Net Cash / Debt	7.98	4.34	11.29
Net Cash / Debt Growth	-	-61.56%	-
Working Capital	-4.71	-7.77	-7.73

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).